Go Pro

Fulcrum Therapeutics (FULC) Institutional Ownership

Fulcrum Therapeutics logo
$3.54 +0.04 (+1.14%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$3.54 0.00 (-0.14%)
As of 05:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Fulcrum Therapeutics (NASDAQ:FULC)

Current
Institutional Ownership
Percentage
89.83%
Number of
Institutional Buyers
(last 12 months)
100
Total
Institutional Inflows
(last 12 months)
$233.28M
Number of
Institutional Sellers
(last 12 months)
52
Total
Institutional Outflows
(last 12 months)
$118.47M
Get FULC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Fulcrum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

FULC Institutional Buying and Selling by Quarter

Fulcrum Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/10/2026 Marquette Asset Management LLC38,552$141K0.0%N/A0.058%
7/9/2026 Hennion & Walsh Asset Management Inc.233,851$856K0.0%N/A0.351%
7/8/2026 Assenagon Asset Management S.A.835,204$3.06M0.0%-30.0%1.253%
6/4/2026Seven Fleet Capital Management LP38,100$292K0.1%N/A0.057%
5/27/2026Westshore Wealth LLC17,000$130K0.0%N/A0.026%
5/19/2026Bank of America Corp DE126,559$971K0.0%-45.3%0.190%
5/19/2026RBF Capital LLC70,000$537K0.0%-13.0%0.105%
5/18/2026ADAR1 Capital Management LLC130,560$1.00M0.1%-90.1%0.196%
5/16/2026The Manufacturers Life Insurance Company 16,102$124K0.0%+25.0%0.024%
5/16/2026Quantinno Capital Management LP25,669$197K0.0%-12.3%0.039%
5/14/2026Renaissance Technologies LLC13,600$104K0.0%-21.8%0.020%
5/14/2026Pale Fire Capital SE26,100$200K0.0%N/A0.039%
5/14/2026Siren L.L.C.2,350,000$18.02M0.5%+20.5%3.527%
5/7/2026Dimensional Fund Advisors LP1,130,281$8.66M0.0%+7.5%1.696%
5/5/2026Bank of New York Mellon Corp149,942$1.15M0.0%+28.3%0.225%
4/30/2026Hsbc Holdings PLC58,636$442K0.0%+35.5%0.088%
4/30/2026Summit Securities Group LLC6,975$53K0.0%N/A0.010%
4/27/2026Simplify Asset Management Inc.115,994$890K0.0%-27.4%0.174%
4/27/2026Y Intercept Hong Kong Ltd153,344$1.18M0.0%+129.8%0.230%
4/20/2026 Assenagon Asset Management S.A.1,193,873$9.16M0.0%N/A1.793%
3/20/2026Hsbc Holdings PLC43,262$498K0.0%-19.6%0.065%
2/19/2026Invesco Ltd.417,189$4.72M0.0%+236.8%0.771%
2/18/2026XTX Topco Ltd51,802$586K0.0%N/A0.096%
2/18/2026Ikarian Capital LLC1,375,472$15.56M1.2%+6.7%2.542%
2/18/2026Vestal Point Capital LP950,000$10.74M0.4%N/A1.755%
2/18/2026Virtus Investment Advisers LLC20,463$231K0.1%N/A0.038%
2/18/2026Wellington Management Group LLP146,427$1.66M0.0%-18.4%0.271%
2/18/2026SummitTX Capital L.P.138,143$1.56M0.0%N/A0.255%
2/18/2026Superstring Capital Management LP72,060$815K0.4%N/A0.133%
2/18/2026Suvretta Capital Management LLC6,561,111$74.21M1.5%+21.9%12.124%
2/18/2026Millennium Management LLC54,431$616K0.0%-63.9%0.101%
2/18/2026Man Group plc15,253$173K0.0%N/A0.028%
2/18/2026Catalio Capital Management LP201,301$2.28M0.4%N/A0.372%
2/18/2026Balyasny Asset Management L.P.970,439$10.98M0.0%-33.1%1.793%
2/18/2026Boothbay Fund Management LLC517,526$5.85M0.1%-23.7%0.956%
2/17/2026Schonfeld Strategic Advisors LLC16,791$190K0.0%-95.4%0.031%
2/17/2026Burkehill Global Management LP50,000$566K0.0%N/A0.092%
2/17/2026AQR Capital Management LLC15,502$175K0.0%N/A0.029%
2/17/2026Braidwell LP3,061,222$34.62M1.1%+1,294.7%5.656%
2/17/2026Jain Global LLC41,260$467K0.0%N/A0.076%
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (Ad)

Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel

See Jeff Brown and Marc Chaikin's full analysis and next steps here
2/17/2026RA Capital Management L.P.6,053,960$68.47M0.7%-40.8%11.186%
2/17/2026Trexquant Investment LP355,547$4.02M0.0%+1,591.9%0.657%
2/17/2026Jump Financial LLC92,200$1.04M0.0%N/A0.170%
2/17/2026Price T Rowe Associates Inc. MD63,760$722K0.0%-3.2%0.118%
2/17/2026Adage Capital Partners GP L.L.C.1,700,000$19.23M0.0%-30.1%3.141%
2/17/2026Russell Investments Group Ltd.3,574$40K0.0%-74.0%0.007%
2/17/2026Atom Investors LP60,595$685K0.1%N/A0.112%
2/17/2026State of Wisconsin Investment Board86,499$978K0.0%+533.0%0.160%
2/17/2026Royal Bank of Canada4,107$47K0.0%-99.6%0.008%
2/17/2026Graham Capital Management L.P.48,464$548K0.0%+59.0%0.090%
2/17/2026Persistent Asset Partners Ltd6,615$75K0.0%N/A0.012%
2/16/2026Squarepoint Ops LLC65,852$745K0.0%+269.4%0.122%
2/16/2026Verition Fund Management LLC74,691$845K0.0%N/A0.138%
2/16/2026Maven Securities LTD100,000$1.13M0.0%N/A0.185%
2/16/2026Nicholas Investment Partners LP182,961$2.07M0.2%N/A0.338%
2/16/2026First Turn Management LLC1,892,683$21.41M2.4%N/A3.497%
2/16/2026Entropy Technologies LP11,996$136K0.0%N/A0.022%
2/16/2026Barclays PLC132,541$1.50M0.0%+47.9%0.245%
2/13/2026Nantahala Capital Management LLC4,293,346$48.56M1.6%-8.1%7.933%
2/13/2026Marshall Wace LLP102,921$1.16M0.0%N/A0.190%
2/13/2026The Manufacturers Life Insurance Company 12,883$146K0.0%-7.6%0.024%
2/13/2026Walleye Capital LLC108,434$1.23M0.0%N/A0.200%
2/13/2026Quarry LP17,165$194K0.0%+354.8%0.032%
2/13/2026Exome Asset Management LLC92,055$1.04M0.5%-6.8%0.170%
2/13/2026Siren L.L.C.1,950,000$22.05M0.7%N/A3.603%
2/13/2026Charles Schwab Investment Management Inc.388,896$4.40M0.0%+16.6%0.719%
2/13/2026State Street Corp1,005,345$11.37M0.0%-5.4%1.858%
2/13/2026Wells Fargo & Company MN166,395$1.88M0.0%+411.9%0.307%
2/12/2026MetLife Investment Management LLC22,714$257K0.0%-12.3%0.042%
2/12/2026GSK plc1,785,714$20.20M2.5%N/A3.300%
2/12/2026Commonwealth Equity Services LLC40,000$452K0.0%-52.1%0.074%
2/12/2026Renaissance Technologies LLC17,400$197K0.0%-93.0%0.032%
2/12/2026Dimensional Fund Advisors LP1,051,124$11.89M0.0%-19.1%1.942%
2/12/2026EntryPoint Capital LLC15,076$171K0.1%N/A0.028%
2/12/2026Integrated Quantitative Investments LLC62,522$707K0.2%N/A0.116%
2/12/2026Informed Momentum Co LLC61,620$697K0.1%N/A0.114%
2/12/2026New York State Common Retirement Fund57,725$653K0.0%+340.6%0.107%
2/12/2026Campbell & CO Investment Adviser LLC35,601$403K0.0%-65.3%0.066%
2/11/2026Meeder Asset Management Inc.3,479$39K0.0%N/A0.006%
2/11/2026Deutsche Bank AG287,096$3.25M0.0%+0.6%0.530%
2/11/2026Fox Run Management L.L.C.25,568$289K0.0%-49.7%0.047%
2/11/2026Franklin Resources Inc.44,249$500K0.0%-26.3%0.082%
2/11/2026WINTON GROUP Ltd14,294$162K0.0%-11.8%0.026%
2/10/2026Goldman Sachs Group Inc.323,879$3.66M0.0%-44.8%0.598%
2/10/2026AXQ Capital LP31,545$357K0.1%N/A0.058%
2/10/2026Intech Investment Management LLC19,747$223K0.0%+14.5%0.036%
2/10/2026Seven Grand Managers LLC50,000$566K0.0%N/A0.092%
2/9/2026Geode Capital Management LLC1,105,813$12.51M0.0%+10.1%2.043%
2/9/2026Simplify Asset Management Inc.159,674$1.81M0.0%+91.8%0.295%
2/6/2026Legato Capital Management LLC66,347$750K0.1%N/A0.123%
Your money is changing (Ad)

Porter Stansberry - who warned readers about Fannie Mae in 2006, called gold in 2008, and predicted COVID-era inflation - believes the U.S. dollar is undergoing its most significant reset since 1974. In a new documentary, Stansberry connects the tariffs, the Greenland obsession, the $1.4 trillion UAE deal, and disputes with China to what he calls Trump's New Dollar - and explains specific steps investors should take before a critical meeting of world leaders this December.tc pixel

Watch the documentary and learn what steps to take now
2/6/2026GSA Capital Partners LLP99,709$1.13M0.1%-14.1%0.184%
2/6/2026ProShare Advisors LLC10,259$116K0.0%N/A0.019%
2/4/2026Bailard Inc.11,781$133K0.0%-56.2%0.022%
2/2/2026Strs Ohio49,300$558K0.0%-36.7%0.091%
1/29/2026Matisse Capital13,460$152K0.1%-27.8%0.025%
1/29/2026China Universal Asset Management Co. Ltd.8,819$100K0.0%N/A0.016%
1/26/2026Mirae Asset Global Investments Co. Ltd.2,630$30K0.0%N/A0.005%
1/23/2026Farther Finance Advisors LLC2,190$25K0.0%-69.2%0.004%
1/23/2026Assetmark Inc.8,184$93K0.0%-14.8%0.015%
1/16/2026Aberdeen Group plc1,254,027$14.18M0.0%+809.0%2.317%


FULC Institutional Ownership - Frequently Asked Questions

During the previous two years, 155 institutional investors and hedge funds held shares of Fulcrum Therapeutics. The most heavily invested institutionals were Suvretta Capital Management LLC ($74.21M), RA Capital Management L.P. ($68.47M), Nantahala Capital Management LLC ($48.56M), Braidwell LP ($34.62M), Vanguard Group Inc. ($27.60M), First Turn Management LLC ($21.41M), and GSK plc ($20.20M).Learn more on Fulcrum Therapeutics' institutional investors.

89.83% of Fulcrum Therapeutics' stock is owned by institutional investors. Learn more on FULC's institutional investor holdings.

Of the 129 institutional investors that purchased Fulcrum Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($4.13M), Suvretta Capital Management LLC ($3.63M), Adage Capital Partners GP L.L.C. ($2.59M), Siren L.L.C. ($2.35M), First Turn Management LLC ($1.89M), GSK plc ($1.79M), and Assenagon Asset Management S.A. ($1.69M).

Institutional investors have bought a total of 23,479,844 shares in the last 24 months. This purchase volume represents approximately $233.28M in transactions.

Of the 52 institutional investors that sold Fulcrum Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RA Capital Management L.P. ($4.18M), ADAR1 Capital Management LLC ($1.19M), Royal Bank of Canada ($996.74K), Nantahala Capital Management LLC ($911.83K), Adage Capital Partners GP L.L.C. ($732K), Balyasny Asset Management L.P. ($480.04K), and Assenagon Asset Management S.A. ($358.67K).

Institutional investors have sold a total of 11,635,289 shares in the last 24 months. This volume of shares sold represents approximately $118.47M in transactions.



This page (NASDAQ:FULC) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners